The Patent Finder

Stcube & Co., Inc.

Also on record
Records under this name other than the patents Stcube & Co., Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Back to Stcube & Co., Inc.

PatentTitleStatus Expires Confidence
US 10,875,920Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 11,970,534Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 12,059,474Methods for Selecting Antibodies That Specifically Bind Glycosylated Immune Checkpoint Proteins
In force
 · High confidence
In forceHigh confidence
15/575,325Screening Methods for Targets for Cancer Therapy
Abandoned
Abandoned Jul 7, 2025
AbandonedAbandoned Jul 7, 2025
16/618,042Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof
Abandoned
Abandoned Nov 15, 2024
AbandonedAbandoned Nov 15, 2024
17/764,098Antibodies Specific to Glycosylated CTLA-4 and Methods of Use Thereof
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/066,879Methods of Treating Cancer Using Antibodies and Molecules That Bind to BTN1A1 or BTN1A1-LIGANDS
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/625,891Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/763,821Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/847,179BTN1A1 Binding Proteins and Methods of Use Thereof
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
10 of 12 records shown.
Pro members see all 12.
Pro members: see all 12 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited